Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 73


Feasibility and validity of the pediatric ulcerative colitis activity index in routine clinical practice.

Dotson JL, Crandall WV, Zhang P, Forrest CB, Bailey LC, Colletti RB, Kappelman MD.

J Pediatr Gastroenterol Nutr. 2015 Feb;60(2):200-4. doi: 10.1097/MPG.0000000000000568.


Routine use of thiopurines in maintaining remission in pediatric Crohn's disease.

Boyle BM, Kappelman MD, Colletti RB, Baldassano RN, Milov DE, Crandall WV.

World J Gastroenterol. 2014 Jul 21;20(27):9185-90. doi: 10.3748/wjg.v20.i27.9185.


PEDSnet: how a prototype pediatric learning health system is being expanded into a national network.

Forrest CB, Margolis P, Seid M, Colletti RB.

Health Aff (Millwood). 2014 Jul;33(7):1171-7. doi: 10.1377/hlthaff.2014.0127.


Effectiveness of anti-TNF╬▒ for Crohn disease: research in a pediatric learning health system.

Forrest CB, Crandall WV, Bailey LC, Zhang P, Joffe MM, Colletti RB, Adler J, Baron HI, Berman J, del Rosario F, Grossman AB, Hoffenberg EJ, Israel EJ, Kim SC, Lightdale JR, Margolis PA, Marsolo K, Mehta DI, Milov DE, Patel AS, Tung J, Kappelman MD.

Pediatrics. 2014 Jul;134(1):37-44. doi: 10.1542/peds.2013-4103. Epub 2014 Jun 16.


Appropriateness of emergency department use in pediatric inflammatory bowel disease: a quality improvement opportunity.

Hoffenberg EJ, Park KT, Dykes DM, Fridge J, Kappelman MD, Leibowitz IH, Tsou VM, Colletti RB.

J Pediatr Gastroenterol Nutr. 2014 Sep;59(3):324-6. doi: 10.1097/MPG.0000000000000457.


Seasonality and pediatric inflammatory bowel disease.

Lee GJ, Dotson JL, Kappelman MD, King E, Pratt JM, Colletti RB, Bistrick S, Burkam JL, Crandall WV; ImproveCareNow Network.

J Pediatr Gastroenterol Nutr. 2014 Jul;59(1):25-8. doi: 10.1097/MPG.0000000000000362.


Implementable strategies and exploratory considerations to reduce costs associated with anti-TNF therapy in inflammatory bowel disease.

Park KT, Crandall WV, Fridge J, Leibowitz IH, Tsou M, Dykes DM, Hoffenberg EJ, Kappelman MD, Colletti RB.

Inflamm Bowel Dis. 2014 May;20(5):946-51. doi: 10.1097/01.MIB.0000441349.40193.aa. Review.


Exemplar pediatric collaborative improvement networks: achieving results.

Billett AL, Colletti RB, Mandel KE, Miller M, Muething SE, Sharek PJ, Lannon CM.

Pediatrics. 2013 Jun;131 Suppl 4:S196-203. doi: 10.1542/peds.2012-3786F.


What's in a name generator? Choosing the right name generators for social network surveys in healthcare quality and safety research.

Burt RS, Meltzer DO, Seid M, Borgert A, Chung JW, Colletti RB, Dellal G, Kahn SA, Kaplan HC, Peterson LE, Margolis P.

BMJ Qual Saf. 2012 Dec;21(12):992-1000. doi: 10.1136/bmjqs-2011-000521. Epub 2012 Sep 1.


Role of sex in the treatment and clinical outcomes of pediatric patients with inflammatory bowel disease.

Lee GJ, Kappelman MD, Boyle B, Colletti RB, King E, Pratt JM, Crandall WV.

J Pediatr Gastroenterol Nutr. 2012 Dec;55(6):701-6. doi: 10.1097/MPG.0b013e318266241b.


Commentaries on "Workshop report: developing a pediatric inflammatory bowel diseases network and data platform in Canada": collaborative chronic care network (C3N) of the future.

Colletti RB.

J Pediatr Gastroenterol Nutr. 2012 Aug;55(2):123-4. doi: 10.1097/MPG.0b013e318260508a. No abstract available.


Safety and efficacy of adalimumab for moderate to severe Crohn's disease in children.

Hyams JS, Griffiths A, Markowitz J, Baldassano RN, Faubion WA Jr, Colletti RB, Dubinsky M, Kierkus J, Rosh J, Wang Y, Huang B, Bittle B, Marshall M, Lazar A.

Gastroenterology. 2012 Aug;143(2):365-74.e2. doi: 10.1053/j.gastro.2012.04.046. Epub 2012 May 2.


Improved outcomes in a quality improvement collaborative for pediatric inflammatory bowel disease.

Crandall WV, Margolis PA, Kappelman MD, King EC, Pratt JM, Boyle BM, Duffy LF, Grunow JE, Kim SC, Leibowitz I, Schoen BT, Colletti RB; ImproveCareNow Collaborative.

Pediatrics. 2012 Apr;129(4):e1030-41. doi: 10.1542/peds.2011-1700. Epub 2012 Mar 12.


Prevalence and epidemiology of overweight and obesity in children with inflammatory bowel disease.

Long MD, Crandall WV, Leibowitz IH, Duffy L, del Rosario F, Kim SC, Integlia MJ, Berman J, Grunow J, Colletti RB, Schoen BT, Patel AS, Baron H, Israel E, Russell G, Ali S, Herfarth HH, Martin C, Kappelman MD; ImproveCareNow Collaborative for Pediatric IBD.

Inflamm Bowel Dis. 2011 Oct;17(10):2162-8. doi: 10.1002/ibd.21585. Epub 2010 Dec 17.


Evidence-based guidelines from ESPGHAN and NASPGHAN for Helicobacter pylori infection in children.

Koletzko S, Jones NL, Goodman KJ, Gold B, Rowland M, Cadranel S, Chong S, Colletti RB, Casswall T, Elitsur Y, Guarner J, Kalach N, Madrazo A, Megraud F, Oderda G; H pylori Working Groups of ESPGHAN and NASPGHAN.

J Pediatr Gastroenterol Nutr. 2011 Aug;53(2):230-43. doi: 10.1097/MPG.0b013e3182227e90.


Pathophysiology, diagnosis, and management of pediatric ascites.

Giefer MJ, Murray KF, Colletti RB.

J Pediatr Gastroenterol Nutr. 2011 May;52(5):503-13. doi: 10.1097/MPG.0b013e318213f9f6. Review.


Development of process and outcome measures for improvement: lessons learned in a quality improvement collaborative for pediatric inflammatory bowel disease.

Crandall WV, Boyle BM, Colletti RB, Margolis PA, Kappelman MD.

Inflamm Bowel Dis. 2011 Oct;17(10):2184-91. doi: 10.1002/ibd.21702. Epub 2011 Mar 31. Review.


Short pediatric Crohn's disease activity index for quality improvement and observational research.

Kappelman MD, Crandall WV, Colletti RB, Goudie A, Leibowitz IH, Duffy L, Milov DE, Kim SC, Schoen BT, Patel AS, Grunow J, Larry E, Fairbrother G, Margolis P.

Inflamm Bowel Dis. 2011 Jan;17(1):112-7. doi: 10.1002/ibd.21452. Epub 2010 Sep 1.


ImproveCareNow: The development of a pediatric inflammatory bowel disease improvement network.

Crandall W, Kappelman MD, Colletti RB, Leibowitz I, Grunow JE, Ali S, Baron HI, Berman JH, Boyle B, Cohen S, del Rosario F, Denson LA, Duffy L, Integlia MJ, Kim SC, Milov D, Patel AS, Schoen BT, Walkiewicz D, Margolis P.

Inflamm Bowel Dis. 2011 Jan;17(1):450-7. doi: 10.1002/ibd.21394. Review.


Effects of esomeprazole treatment for gastroesophageal reflux disease on quality of life in 12- to 17-year-old adolescents: an international health outcomes study.

Gunasekaran T, Tolia V, Colletti RB, Gold BD, Traxler B, Illueca M, Crawley JA.

BMC Gastroenterol. 2009 Nov 18;9:84. doi: 10.1186/1471-230X-9-84.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk